Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Revenue to net income

Key figures

MetricLatest5-year CAGR
Revenue$16.9B+11.0%
Gross profit$6.2B2019+18.0%
Operating income$4.9B0.0%
Net income$4.8B+5.1%
EPS$45.29+6.3%
Free cash flow$3.8B+15.3%